Inhibition of a cellular stress response may be a therapeutic target for ALS type 8 related to mutations in the VAPB gene, a ...

Neurologist and Duke ALS Clinic Director Richard Bedlack “stitches strength” for his patients, showing the powers of hope.

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the ...

Exposure to rhodamine B (RhB), a toxic fluorescent dye, causes neurodegeneration, symptoms that resemble ALS, and molecular ...

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose ...

Apathy and depression are the most prevalent neuropsychiatric symptoms in amyotrophic lateral sclerosis (ALS).1-3 Although ...

Dampening the integrated stress response (IRS) in motor neurons may be a valid therapeutic approach in patients with an inherited form of ALS.

Some patients who’ve suffered from oral cancers or neurological diseases like ALS are starting to use the technology to regain natural voices that they lost.

Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in ...